Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease

ABSTRACT

Objective: The aim of this in vitro study was to formulate an in situ thermoreversible injectable gel with poloxamer (PM) and methylcellulose (MC) to deliver simvastatin (SMV) in a controlled manner. Subjects and Methods: Preformulation studies (Fourier transform infrared and differential scanning calorimetry) to assess the interaction between SMV and MC and PM were performed before gel formulation. Keeping the concentration of SMV at 2.2%, the concentration of PM and MC was altered to formulate in situ thermosensitive gel at 37°C. Rheological studies were carried to analyze the physical property of the various formulations. Drug release profile and stability studies were done for the selected formulation. Thein vitro drug release profile was carried out for using open end tube method and ultraviolet spectroscopy. Results:The preformulation studies showed that there is no interaction between the polymer and drug based on the rheological studies of different formulation, the formulation. F8 gels at 37°C and attains a viscosity of 4150 cps. Conclusions: PM 25% and MC 5% formed an ideal thermosensitive injectable gel at 37°C for subgingival delivery of SMV and also show controlled drug release for the period of 10 days in vitro.

KEYWORDS

• In situ gel
• periodontitis
• simvastatin

Showing references and in-text citations exactly as published.

• DOI10.4103/jphi.JPHI_26_17Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPI.

• Article · VOLUME 7, ISSUE 2Determining frequency of genes of CTX‑M and CTX‑M‑15 of producing Enterobacteriaceae of isolated extended‑spectrum beta‑lactamases from clinical samples of patients referred to training hospitals of Medical Sciences University, Khorramabad, IranSeyed Mojtaba Mosavian, Azam Rezvani‑Rad · pp. 60–69Original Research ArticleSame type: Article
• Article · VOLUME 7, ISSUE 2Brand versus generic dispensing trend for ciprofloxacin 500 mg, levofloxacin 500 mg, and moxifloxacin 400 mg (oral dosage forms) among pharmacies of Karachi, PakistanFatima Zehra, Atta Abbas Naqvi, Sumbul Tasneem, Rizwan Ahmad, Niyaz Ahmad, Adnan Zia Shamsi, Naqiya Ali Asghar, Ghufran Ullah Khan · pp. 70–76Original Research ArticleSame type: Article
• Article · VOLUME 7, ISSUE 2Antifungal effects of Lactobacillus species isolated from local dairy productsSahar Karami, Mohammad Roayaei, Elnaz Zahedi, Mahmoud Bahmani, Leila Mahmoodnia, Hosna Hamzavi, Mahmoud Rafieian-Kopaei · pp. 77–81Original Research ArticleSame type: Article
• Article · VOLUME 7, ISSUE 2Synergistic effect of Carum copticum and Mentha piperita essential oils with ciprofloxacin, vancomycin, and gentamicin on Gram‑negative and Gram‑positive bacteriaGholam-Reza Talei, Mohsen Mohammadi, Mahmoud Bahmani, Mahmoud Rafieian Kopaei · pp. 82–87Original Research ArticleSame type: Article